A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation

Tissue Engineering - Part C: Methods

Volumn 17, Issue 4, 2011, Pages 463-473

  Kensah, George ^a,b   Gruh, Ina ^a,b   Viering, Jörg ^a   Schumann, Henning ^a   Dahlmann, Julia ^a,b   Meyer, Heiko ^b,c   Skvorc, David ^a,b   Bär, Antonia ^a,e   Akhyari, Payam ^a,f   Heisterkamp, Alexander ^b,c,d   Haverich, Axel ^a,b   Martin, Ulrich ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Rebirth   (Germany)

^c INSTITUT FÜR QUANTENOPTIK   (Germany)

^d LASER ZENTRUM HANNOVER E V   (Germany)

^e Heart Institute Lahr/Baden   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCONVERSION; BIOELECTRIC PHENOMENA; BIOREACTORS; CELL CULTURE; HEART; MONITORING; STEM CELLS; TISSUE;

BIOARTIFICIAL; BIOREACTOR SYSTEM; CARDIAC TISSUE ENGINEERING; CARDIAC TISSUES; CARDIOMYOCYTES; CELL ORIENTATION; CELL-BASED; CONTINUOUS CULTIVATION; CONTRACTION FORCE MEASUREMENT; CULTURE CHAMBERS; CYCLIC STRETCH; ELECTRICAL STIMULATIONS; ELEVATED LEVEL; ENRICHMENT TECHNIQUES; FUNCTIONAL FEATURES; IN-CONTROL; IN-SITU ASSESSMENT; IN-SITU MONITORING; ISOFORMS; MECHANICAL STIMULATION; MULTI-MODAL; MYOSIN HEAVY CHAIN; NATRIURETIC FACTOR; NORADRENALIN; REGENERATIVE MEDICINE; SYNERGISTIC EFFECT; TISSUE DEVELOPMENT; TISSUE REPLACEMENT;

TISSUE ENGINEERING;

RATTUS;

BIOLOGICAL MARKER;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; ARTIFICIAL ORGAN; BIOREACTOR; CELL SURVIVAL; CYTOLOGY; ELECTRONICS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART CONTRACTION; HEART MUSCLE CELL; INSTRUMENTATION; MECHANICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING;

ANIMALS; ARTIFICIAL ORGANS; BIOLOGICAL MARKERS; BIOREACTORS; CELL SURVIVAL; GENE EXPRESSION REGULATION; HEART; MECHANICAL PHENOMENA; MICROSCOPY, FLUORESCENCE; MINIATURIZATION; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING;

EID: 79953659765     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2010.0405     Document Type: Article

References (40)

1. WHO. Fact sheet No. 317. Cardiovascular diseases. 2009.
2. Zimmermann, W.H., Melnychenko, I., and Eschenhagen, T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 25, 1639, 2004.
3. Akhyari, P., Kamiya, H., Haverich, A., Karck, M., and Lichtenberg, A. Myocardial tissue engineering: the extracellular matrix. Eur J Cardiothorac Surg 34, 229, 2008.
4. Dor, V., Sabatier, M., Montiglio, F., Civaia, F., and DiDonato, M. Endoventricular patch reconstruction of ischemic failing ventricle. a single center with 20 years experience. advantages of magnetic resonance imaging assessment. Heart Fail Rev 9, 269, 2004.
5. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108, 407, 2001.
6. Schwanke, K., Wunderlich, S., Reppel, M., Winkler, M.E., Matzkies, M., Groos, S., et al. Generation and characterization of functional cardiomyocytes from rhesus monkey embryonic stem cells. Stem Cells 24, 1423, 2006.
7. Schenke-Layland, K., Rhodes, K.E., Angelis, E., Butylkova, Y., Heydarkhan-Hagvall, S., Gekas, C., et al. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 26, 1537, 2008.
8. Mauritz, C., Schwanke, K., Reppel, M., Neef, S., Katsirntaki, K., Maier, L.S., et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507, 2008.
9. Zhang, J., Wilson, G.F., Soerens, A.G., Koonce, C.H., Yu, J., Palecek, S.P., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104, e30, 2009.
10. Haase, A., Olmer, R., Schwanke, K., Wunderlich, S., Merkert, S., Hess, C., et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434, 2009.
11. Zweigerdt, R. Large scale production of stem cells and their derivatives. Adv Biochem Eng Biotechnol 114, 201, 2009.
12. Olmer, R., Haase, A., Merkert, S., Cui, W., Palecek, J., Ran, C., et al. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res 5, 51, 2010.
13. Xu, X.Q., Graichen, R., Soo, S.Y., Balakrishnan, T., Rahmat, S.N., Sieh, S., et al. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 76, 958, 2008.
14. Fink, C., Ergun, S., Kralisch, D., Remmers, U., Weil, J., and Eschenhagen, T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J 14, 669, 2000.
15. Zimmermann, W.H., Schneiderbanger, K., Schubert, P., Didie, M., Munzel, F., Heubach, J.F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90, 223, 2002.
16. Birla, R.K., Borschel, G.H., and Dennis, R.G. In vivo conditioning of tissue-engineered heart muscle improves contractile performance. Artif Organs 29, 866, 2005.
17. Akhyari, P., Fedak, P.W., Weisel, R.D., Lee, T.Y., Verma, S., Mickle, D.A., et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 106, I137, 2002.
18. Barki-Harrington, L., Perrino, C., and Rockman, H.A. Network integration of the adrenergic system in cardiac hypertrophy. Cardiovasc Res 63, 391, 2004.
19. Frank, D., Kuhn, C., Brors, B., Hanselmann, C., Ludde, M., Katus, H.A., et al. Gene expression pattern in biomechani-cally stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 51, 309, 2008.
20. Komuro, I., and Yazaki, Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 55, 55, 1993.
21. Zhang, Y.H., Youm, J.B., and Earm, Y.E. Stretch-activated non-selective cation channel: a causal link between mechanical stretch and atrial natriuretic peptide secretion. Prog Biophys Mol Biol 98, 1, 2008.
22. Naito, H., Melnychenko, I., Didie, M., Schneiderbanger, K., Schubert, P., Rosenkranz, S., et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114, I72, 2006.
23. Hansen, A., Eder, A., Bonstrup, M., Flato, M., Mewe, M., Schaaf, S., et al. Development of a drug screening platform based on engineered heart tissue. Circ Res 107, 35, 2010.
24. Wollert, K.C., Taga, T., Saito, M., Narazaki, M., Kishimoto, T., Glembotski, C.C., et al. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 271, 9535, 1996.
25. Claycomb, W.C., Lanson, N.A., Jr., Stallworth, B.S., Egeland, D.B., Delcarpio, J.B., Bahinski, A., et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95, 2979, 1998.
26. Hattori, F., Chen, H., Yamashita, H., Tohyama, S., Satoh, Y.S., Yuasa, S., et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods 7, 61, 2010.
27. Frey, N., and Olson, E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65, 45, 2003.
28. Black, L.D., 3rd, Meyers, J.D., Weinbaum, J.S., Shvelidze, Y.A., and Tranquillo, R.T. Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng Part A 15, 3099, 2009.
29. Salameh, A., Wustmann, A., Karl, S., Blanke, K., Apel, D., Rojas-Gomez, D., et al. Cyclic mechanical stretch induces cardiomyocyte orientation and polarization of the gap junction protein connexin 43. Circ Res 106, 1592, 2010.
30. Salameh, A., Karl, S., Djilali, H., Dhein, S., Janousek, J., and Daehnert, I. Opposing and synergistic effects of cyclic mechanical stretch and alpha- or beta-adrenergic stimulation on the cardiac gap junction protein Cx43. Pharmacol Res 62, 506, 2010.
31. Shimko, V.F., and Claycomb, W.C. Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes. Tissue Eng Part A 14, 49, 2008.
32. Simpson, P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. J Clin Invest 72, 732, 1983.
33. Izumo, S., Nadal-Ginard, B., and Mahdavi, V. Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85, 339, 1988.
34. Lesman, A., Habib, M., Caspi, O., Gepstein, A., Arbel, G., Levenberg, S., et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A 16, 115, 2010.
35. Martinez, E.C., Wang, J., Gan, S.U., Singh, R., Lee, C.N., and Kofidis, T. Ascorbic acid improves embryonic cardiomyo-blast cell survival and promotes vascularization in potential myocardial grafts in vivo. Tissue Eng Part A 16, 1349, 2010.
36. Zimmermann, W.H., Melnychenko, I., Wasmeier, G., Didie, M., Naito, H., Nixdorff, U., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12, 452, 2006.
37. Clause, K.C., Tinney, J.P., Liu, L.J., Keller, B.B., and Tobita, K. Engineered early embryonic cardiac tissue increases car-diomyocyte proliferation by cyclic mechanical stretch via p38-MAP kinase phosphorylation. Tissue Eng Part A 15, 1373, 2009.
38. Zimmermann, W.H., Fink, C., Kralisch, D., Remmers, U., Weil, J., and Eschenhagen, T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68, 106, 2000.
39. Brooks, W.W., and Conrad, C.H. Differences between mouse and rat myocardial contractile responsiveness to calcium. Comp Biochem Physiol A Mol Integr Physiol 124, 139, 1999.
40. Han, Y.S., and Ogut, O. Regulation of fibre contraction in a rat model of myocardial ischemia. PLoS One 5, e9528, 2010.